Covington Capital Management’s Mesoblast MESO Stock Holding History

Covington Capital Management’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1K	Hold	250	–	–	﹤0.01%	1138
2022 Q2	$1K	Buy	+250	New	+$1.72K	﹤0.01%	1039

Other funds holding MESO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

Covington Capital Management's MESO Position: Q3 2022 in Review

Covington Capital Management held its Mesoblast (MESO) position steady in Q3 2022 at 250 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1138.

Covington Capital Management first reported a position in MESO in Q2 2022 and has held it in 2 quarters since. 37 funds tracked by Wall St. Rank hold MESO as of Q3 2022.

Covington Capital Management held 250 shares of Mesoblast worth $1K as of Q3 2022.
Covington Capital Management left its Mesoblast share count unchanged in Q3 2022.
Mesoblast made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #1138 holding.
Covington Capital Management first reported a position in Mesoblast in Q2 2022 and has held it in 2 quarters since.
37 funds tracked by Wall St. Rank held Mesoblast as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.